Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axisYe Yan(Chinese Academy of Sciences), Chunde Bao(Renji Hospital)Arthritis Research & TherapyApril 11, 201910.1186/s13075-019-1874-2Cited by 87SaveCiteExport RISWatch citationsRelated PapersERK/GSK3β signaling is involved in atractylenolide I-induced apoptosis and cell cycle arrest in melanoma cells|Oncology Reports|2015|22